Cardiac channelopathies and sudden infant death syndrome

Peter J. Schwartz, Marco Stramba-Badiale, John R. Giudicessi, David J. Tester, Lia Crotti, Michael John Ackerman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Sudden Infant Death Syndrome (SIDS) represents the leading cause of postneonatal sudden death in developed countries, the third leading cause of infant mortality overall in the United States, and a source of devastating psychosocial consequences for the families of victims. This chapter (i) describes the cardiac QT hypothesis for SIDS according to which some cases of SIDS might be due to ventricular fibrillation associated with prolonged repolarization, (ii) summarizes the results of an 18-year long prospective study with electrocardiogram (ECG) recordings in over 34,000 infants, (iii) discusses recent findings which provide the molecular and functional evidence linking SIDS to cardiac channelopathies like the congenital long QT syndrome (LQTS), Short QT syndrome (SQTS), Brugada syndrome (BrS), and catecholaminergic polymorphic ventricular tachycardia (CPVT), (iv) presents the results of a prospective ECG study involving 45,000 infants which provided the first opportunity for a data-driven assessment of the prevalence of LQTS and summarizes the main finding of a cost-effectiveness study which analyzes a screening neonatal ECG program in a large European country, and (v) addresses the implications of 35 plus years of research on LQTS and SIDS. The studies presented here provide the conclusive evidence that genetically mediated arrhythmias represent a significant and non-dismissible cause of SIDS and support the concept of widespread neonatal ECG screening for the identification of a subset of infants at high risk for sudden death that can be prevented as it is the case with most patients affected by LQTS.

Original languageEnglish (US)
Title of host publicationElectrical Diseases of the Heart: Volume 2: Diagnosis and Treatment, Second Edition
PublisherSpringer-Verlag London Ltd
Pages381-394
Number of pages14
ISBN (Print)9781447149781, 9781447149774
DOIs
StatePublished - Jan 1 2013

Fingerprint

Channelopathies
Sudden Infant Death
Long QT Syndrome
Electrocardiography
Neonatal Screening
Sudden Death
Prospective Studies
Brugada Syndrome
Infant Mortality
Ventricular Fibrillation
Developed Countries
Cost-Benefit Analysis
Cardiac Arrhythmias
Research

Keywords

  • Channelopathies
  • Long QT syndrome
  • Neonatal ECG screening
  • Sudden infant death syndrome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Schwartz, P. J., Stramba-Badiale, M., Giudicessi, J. R., Tester, D. J., Crotti, L., & Ackerman, M. J. (2013). Cardiac channelopathies and sudden infant death syndrome. In Electrical Diseases of the Heart: Volume 2: Diagnosis and Treatment, Second Edition (pp. 381-394). Springer-Verlag London Ltd. https://doi.org/10.1007/978-1-4471-4978-1_24

Cardiac channelopathies and sudden infant death syndrome. / Schwartz, Peter J.; Stramba-Badiale, Marco; Giudicessi, John R.; Tester, David J.; Crotti, Lia; Ackerman, Michael John.

Electrical Diseases of the Heart: Volume 2: Diagnosis and Treatment, Second Edition. Springer-Verlag London Ltd, 2013. p. 381-394.

Research output: Chapter in Book/Report/Conference proceedingChapter

Schwartz, PJ, Stramba-Badiale, M, Giudicessi, JR, Tester, DJ, Crotti, L & Ackerman, MJ 2013, Cardiac channelopathies and sudden infant death syndrome. in Electrical Diseases of the Heart: Volume 2: Diagnosis and Treatment, Second Edition. Springer-Verlag London Ltd, pp. 381-394. https://doi.org/10.1007/978-1-4471-4978-1_24
Schwartz PJ, Stramba-Badiale M, Giudicessi JR, Tester DJ, Crotti L, Ackerman MJ. Cardiac channelopathies and sudden infant death syndrome. In Electrical Diseases of the Heart: Volume 2: Diagnosis and Treatment, Second Edition. Springer-Verlag London Ltd. 2013. p. 381-394 https://doi.org/10.1007/978-1-4471-4978-1_24
Schwartz, Peter J. ; Stramba-Badiale, Marco ; Giudicessi, John R. ; Tester, David J. ; Crotti, Lia ; Ackerman, Michael John. / Cardiac channelopathies and sudden infant death syndrome. Electrical Diseases of the Heart: Volume 2: Diagnosis and Treatment, Second Edition. Springer-Verlag London Ltd, 2013. pp. 381-394
@inbook{7ca7edd8a79045bebca56079909d45c4,
title = "Cardiac channelopathies and sudden infant death syndrome",
abstract = "Sudden Infant Death Syndrome (SIDS) represents the leading cause of postneonatal sudden death in developed countries, the third leading cause of infant mortality overall in the United States, and a source of devastating psychosocial consequences for the families of victims. This chapter (i) describes the cardiac QT hypothesis for SIDS according to which some cases of SIDS might be due to ventricular fibrillation associated with prolonged repolarization, (ii) summarizes the results of an 18-year long prospective study with electrocardiogram (ECG) recordings in over 34,000 infants, (iii) discusses recent findings which provide the molecular and functional evidence linking SIDS to cardiac channelopathies like the congenital long QT syndrome (LQTS), Short QT syndrome (SQTS), Brugada syndrome (BrS), and catecholaminergic polymorphic ventricular tachycardia (CPVT), (iv) presents the results of a prospective ECG study involving 45,000 infants which provided the first opportunity for a data-driven assessment of the prevalence of LQTS and summarizes the main finding of a cost-effectiveness study which analyzes a screening neonatal ECG program in a large European country, and (v) addresses the implications of 35 plus years of research on LQTS and SIDS. The studies presented here provide the conclusive evidence that genetically mediated arrhythmias represent a significant and non-dismissible cause of SIDS and support the concept of widespread neonatal ECG screening for the identification of a subset of infants at high risk for sudden death that can be prevented as it is the case with most patients affected by LQTS.",
keywords = "Channelopathies, Long QT syndrome, Neonatal ECG screening, Sudden infant death syndrome",
author = "Schwartz, {Peter J.} and Marco Stramba-Badiale and Giudicessi, {John R.} and Tester, {David J.} and Lia Crotti and Ackerman, {Michael John}",
year = "2013",
month = "1",
day = "1",
doi = "10.1007/978-1-4471-4978-1_24",
language = "English (US)",
isbn = "9781447149781",
pages = "381--394",
booktitle = "Electrical Diseases of the Heart: Volume 2: Diagnosis and Treatment, Second Edition",
publisher = "Springer-Verlag London Ltd",

}

TY - CHAP

T1 - Cardiac channelopathies and sudden infant death syndrome

AU - Schwartz, Peter J.

AU - Stramba-Badiale, Marco

AU - Giudicessi, John R.

AU - Tester, David J.

AU - Crotti, Lia

AU - Ackerman, Michael John

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Sudden Infant Death Syndrome (SIDS) represents the leading cause of postneonatal sudden death in developed countries, the third leading cause of infant mortality overall in the United States, and a source of devastating psychosocial consequences for the families of victims. This chapter (i) describes the cardiac QT hypothesis for SIDS according to which some cases of SIDS might be due to ventricular fibrillation associated with prolonged repolarization, (ii) summarizes the results of an 18-year long prospective study with electrocardiogram (ECG) recordings in over 34,000 infants, (iii) discusses recent findings which provide the molecular and functional evidence linking SIDS to cardiac channelopathies like the congenital long QT syndrome (LQTS), Short QT syndrome (SQTS), Brugada syndrome (BrS), and catecholaminergic polymorphic ventricular tachycardia (CPVT), (iv) presents the results of a prospective ECG study involving 45,000 infants which provided the first opportunity for a data-driven assessment of the prevalence of LQTS and summarizes the main finding of a cost-effectiveness study which analyzes a screening neonatal ECG program in a large European country, and (v) addresses the implications of 35 plus years of research on LQTS and SIDS. The studies presented here provide the conclusive evidence that genetically mediated arrhythmias represent a significant and non-dismissible cause of SIDS and support the concept of widespread neonatal ECG screening for the identification of a subset of infants at high risk for sudden death that can be prevented as it is the case with most patients affected by LQTS.

AB - Sudden Infant Death Syndrome (SIDS) represents the leading cause of postneonatal sudden death in developed countries, the third leading cause of infant mortality overall in the United States, and a source of devastating psychosocial consequences for the families of victims. This chapter (i) describes the cardiac QT hypothesis for SIDS according to which some cases of SIDS might be due to ventricular fibrillation associated with prolonged repolarization, (ii) summarizes the results of an 18-year long prospective study with electrocardiogram (ECG) recordings in over 34,000 infants, (iii) discusses recent findings which provide the molecular and functional evidence linking SIDS to cardiac channelopathies like the congenital long QT syndrome (LQTS), Short QT syndrome (SQTS), Brugada syndrome (BrS), and catecholaminergic polymorphic ventricular tachycardia (CPVT), (iv) presents the results of a prospective ECG study involving 45,000 infants which provided the first opportunity for a data-driven assessment of the prevalence of LQTS and summarizes the main finding of a cost-effectiveness study which analyzes a screening neonatal ECG program in a large European country, and (v) addresses the implications of 35 plus years of research on LQTS and SIDS. The studies presented here provide the conclusive evidence that genetically mediated arrhythmias represent a significant and non-dismissible cause of SIDS and support the concept of widespread neonatal ECG screening for the identification of a subset of infants at high risk for sudden death that can be prevented as it is the case with most patients affected by LQTS.

KW - Channelopathies

KW - Long QT syndrome

KW - Neonatal ECG screening

KW - Sudden infant death syndrome

UR - http://www.scopus.com/inward/record.url?scp=84949427694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949427694&partnerID=8YFLogxK

U2 - 10.1007/978-1-4471-4978-1_24

DO - 10.1007/978-1-4471-4978-1_24

M3 - Chapter

SN - 9781447149781

SN - 9781447149774

SP - 381

EP - 394

BT - Electrical Diseases of the Heart: Volume 2: Diagnosis and Treatment, Second Edition

PB - Springer-Verlag London Ltd

ER -